Exercise-based Cardiac Rehabilitation for Atrial Fibrillation

NCT ID: NCT06401148

Last Updated: 2024-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-22

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators aim to conduct a pilot randomised controlled trial (RCT) with embedded feasibility study to evaluate an exercise-based cardiac rehabilitation (ExCR) programme when delivered to patients with atrial fibrillation on the waiting list for catheter ablation. Our overall objective is to test the feasibility and acceptability of an evidence-based ExCR intervention prior to evaluation in a future randomized controlled trial (RCT).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A two-arm pilot randomised feasibility trial (RCT) with embedded process evaluation will be undertaken as a phased programme of work. Patients on a waiting list for catheter ablation will be offered a referral to cardiac rehabilitation. The intervention consists of supervised exercise sessions run by a clinical exercise physiologist and psychoeducation sessions. The trial will involve one National Health Service (NHS) research site, Liverpool Heart and Chest NHS Foundation Trust enrolling patients (n=60) to assess intervention and study design processes. Primary outcomes are recruitment rate, adherence to the ExCR and loss to follow-up. Semi-structured interviews and focus groups with patients and clinicians will be used to gather data on the acceptability of the intervention and study procedures. Secondary outcome measures will be taken at baseline (preintervention), postintervention and at 6 month follow-up for both phases and will consist of exercise capacity measured by AF burden, AF recurrence, quality of life, exercise capacity, and cardiac structure and function.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exercise-based cardiac rehabilitation

Participants will complete an 8-week-long cardiac rehabilitation programme consisting of supervised exercise sessions run by a clinical exercise physiologist and psychoeducation sessions.

Group Type EXPERIMENTAL

Cardiac rehab intervention group

Intervention Type BEHAVIORAL

Participants will complete an 8-week cardiac rehabilitation programme supported by the onsite CR service.

Treatment as Usual

Participants randomised to usual care will not receive any intervention but continue with usual medical treatment for their AF as determined by their healthcare team.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cardiac rehab intervention group

Participants will complete an 8-week cardiac rehabilitation programme supported by the onsite CR service.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant is willing and able to give informed consent for participation in the study.
* Aged ≥18 years.
* Diagnosed with AF and on a waiting list or referred for medical treatment for symptomatic AF (eg catheter ablation).
* Is eligible and willing to take part in an ExCR programme.

Exclusion Criteria

* Blood pressure \>180/100.
* Unstable angina.
* Severe valvular heart disease as diagnosed by echocardiography.
* Heart failure New York Heart Association (NYHA) class 4.
* \<6 months post-transplant.
* Resting/uncontrolled tachycardia.
* Stroke in last 6 weeks.
* Cardiac sarcoidosis.
* Injury or disability preventing exercise.
* Inability to understand trial procedures e.g. difficulties with speaking and understanding the English language.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Liverpool Heart and Chest Hospital NHS Foundation Trust

OTHER

Sponsor Role collaborator

Liverpool John Moores University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Benjamin Buckley, PhD

Role: PRINCIPAL_INVESTIGATOR

Liverpool John Moores University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Liverpool John Moores University

Liverpool, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Benjamin Buckley, PhD

Role: CONTACT

‭0151 231 2121‬

Charlotte Fitzhugh, MSc

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Benjamin Buckley

Role: primary

0151 231 2121‬

Charlotte Fitzhugh

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Fitzhugh C, Jones H, Foweather L, Lip GYH, Gupta D, Mills MT, Buckley BJ. Exercise-based cardiac rehabilitation for patients with atrial fibrillation receiving catheter ablation: protocol for a feasibility randomised controlled trial (RCT) with embedded process evaluation. BMJ Open. 2025 Jan 30;15(1):e088460. doi: 10.1136/bmjopen-2024-088460.

Reference Type DERIVED
PMID: 39890138 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Interventional

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exercise Effects on Atrial Fibrillation
NCT06607510 NOT_YET_RECRUITING NA
Exercise Training to Atrial Fibrillation
NCT04508478 ACTIVE_NOT_RECRUITING NA